Representative Lisa C. McClain (R-Michigan) recently bought shares of Option Care Health, Inc. (NASDAQ:OPCH). In a filing disclosed on October 22nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Option Care Health stock on September 25th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.
Representative Lisa C. McClain also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of FMC (NYSE:FMC) on 9/25/2025.
- Sold $1,001 – $15,000 in shares of Merit Medical Systems (NASDAQ:MMSI) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of Darden Restaurants (NYSE:DRI) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of Kenvue (NYSE:KVUE) on 9/25/2025.
- Sold $1,001 – $15,000 in shares of Beacon Financial (NYSE:BBT) on 9/25/2025.
- Sold $1,001 – $15,000 in shares of British American Tobacco (NYSE:BTI) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of Rollins (NYSE:ROL) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of MGP Ingredients (NASDAQ:MGPI) on 9/25/2025.
Option Care Health Stock Down 0.5%
Shares of NASDAQ:OPCH opened at $27.91 on Friday. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The firm has a market capitalization of $4.53 billion, a P/E ratio of 22.33, a P/E/G ratio of 1.70 and a beta of 0.88. The stock has a 50 day moving average price of $27.99 and a 200-day moving average price of $30.11. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.
Analyst Ratings Changes
A number of equities research analysts have commented on OPCH shares. Cowen started coverage on Option Care Health in a report on Thursday, October 2nd. They set a “hold” rating on the stock. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Tuesday, September 23rd. JMP Securities boosted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. TD Cowen assumed coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating and a $30.00 target price for the company. Finally, Citigroup restated an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Nine investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $35.10.
Check Out Our Latest Analysis on OPCH
Hedge Funds Weigh In On Option Care Health
A number of large investors have recently made changes to their positions in the business. Durable Capital Partners LP increased its position in shares of Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in Option Care Health by 30.8% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock valued at $146,947,000 after purchasing an additional 989,048 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Option Care Health by 109.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after purchasing an additional 1,778,279 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Option Care Health by 4.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock valued at $91,209,000 after purchasing an additional 99,574 shares during the last quarter. Finally, Norges Bank purchased a new stake in Option Care Health in the second quarter valued at $69,932,000. 98.05% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Option Care Health
In other Option Care Health news, Director Norman L. Wright purchased 3,411 shares of the stock in a transaction on Tuesday, September 9th. The shares were bought at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the acquisition, the director owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction on Thursday, August 21st. The stock was acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares of the company’s stock, valued at $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 59,411 shares of company stock valued at $1,627,576. 0.64% of the stock is owned by insiders.
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- The 3 Best Retail Stocks to Shop for in August
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- Earnings Per Share Calculator: How to Calculate EPS
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- What is the Nikkei 225 index?
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
